Status:
COMPLETED
Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Prostatic Hyperplasia
Eligibility:
MALE
Brief Summary
The primary objective of this observational study was the assessment of prognosis factors for having recourse to prostatic surgery in patients with BPH who were administered class-1 alpha blockers. Th...
Eligibility Criteria
Inclusion
- Any patient with BPH for whom alpha-blocker treatment is indicated
- Patients who are already on class-1 alpha-blockers can only participate in the study if all information required is known and/or available
Exclusion
- Patient's follow-up not possible
- Patients participating in another study
- History of BPH surgery
- Prostate cancer
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
4561 Patients enrolled
Trial Details
Trial ID
NCT02244307
Start Date
January 1 2000
Last Update
September 19 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.